Proteomics Market

Proteomics Market Size by Product Type (Instruments, Services, Reagents and Consumables and Others), Application (Drug Discovery, Clinical Diagnostics and Others), Technology (Microarray Instruments, Spectroscopy, Protein Fractionation Systems, Surface Plasma Resonance Systems, X-ray crystallography, Chromatography, and Electrophoresis), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13753
  • Published Date: Oct, 2023
  • Pages: 238
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global proteomics market was valued at USD 25 billion in 2022 and grew at a CAGR of 15% from 2023 to 2032. The market is expected to reach USD 101.13 billion by 2032. The technological advancements will drive the growth of the global proteomics market.

Market Introduction:

The study of proteins' relationships, biological functions, makeup, and architectures is known as proteomics. Proteomics aims to create a comprehensive 3-D map of every protein interaction in a cell. The most promising use of proteomics is screening particular subsets of protein biomarkers for particular disorders. With the aid of proteomics, an era of customized, patient-tailored therapy is quickly approaching. The discipline of proteomics can identify proteins implicated in disease pathogenesis and reconstruct physiological pathways, which makes it easier to identify new, unique medication targets, their corresponding mechanisms of action, and their biological toxicity.

Proteomics Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • September 2023 - To provide their clients with the 7,000-plex SomaScan platform, SomaLogic Inc., a pioneer in data-driven proteomics technology, announced its cooperation with DNA Link, a pioneer in personalized and precision medicine. The first SomaLogic-approved website in Korea will be DNA Link. The 7,000-plex SomaScan test from SomaLogic will considerably increase DNA Link's proteomics capabilities in its Seoul, Korea, facility. With an emphasis on genetic epidemiology, drug discovery, and personalized medicine, DNA Link has performed genomics research out of its facilities for over 20 years. Their multiomics products are offered in Asia, including Korea.

Market Dynamics:

Drivers

The technological advancements The technological advancements in the past decade, combined with scientific research and breakthroughs, have led to the development of enhanced techniques, devices, instruments and software that improve proteomics. More accuracy, reliability, precision, and faster results have defined technological advancements in proteomics. This has led to expanding proteomics applications from drug discovery to clinical diagnosis. With the increasing incidence of chronic illnesses, these advancements will bode well for the growth and application of proteomics. Therefore, technological advancements will drive the global proteomics market's growth.

  • September 2023 - The Bruker Corporation revealed advancements in instrumental techniques, supplies, and software for 4D-Proteomics during the 22nd Human Proteome Organisation World Congress in 2023. A scalable, CCS-enabled, label-free quantification technique called TIMSquant is now available from Bruker and integrated with ProteoScape. TIMSquant uses global retention time and collision cross-section (CCS) prediction models to accurately quantify the peptides and proteins in 100s or 1000s samples.
Restraints:

The high costs of proteomics proteomics uses sophisticated equipment, devices, reagents, consumables, and other expensive technologies. Qualified and trained professionals operate these. Proteomics requires a specific setup and infrastructure. Therefore, the high cost of proteomics will hamper the market's growth.

Opportunities:

The increasing applications of proteomics the success of proteomics in biomedicine has led to increased research and development to explore its applications. The emerging economies are also investing in proteomics. The collaborations and partnerships drive innovation in proteomics, which will bode well for the market during the forecast period.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest global proteomics market, with a 38% market revenue share in 2022.

Key market players in proteomics are headquartered in the region. These market players' most advanced research and development facilities are situated in the region and drive innovation in biomedicine using proteomics. The region is home to the most advanced medical technologies, research institutes, human resources and funding, which augments the market's development and growth.

North America Region Proteomics Market Share in 2022 - 38%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • September 2023 - Proteomics is about to change, given the new single-molecule protein sequencing platform. Every lab may soon have access to cheap benchtop protein sequencing with automated analysis with Quantum-Si's cutting-edge PlatinumTM protein sequencing platform.
Product type Segment Analysis

The product type segment is divided into instruments, services, reagents and consumables and others. The reagents and consumables segment dominated the market, with a market share of around 53% in 2022. Reagents are an integral part of any chemical reaction. They facilitate experiments. Similarly, consumables are tools or goods used once for one activity, and a new activity needs a new good. The disposable nature increases the frequency of reagents and consumables being used, explaining their dominance in the segment.

Application Segment Analysis

The application segment is divided into drug discovery, clinical diagnostics and others. The clinical diagnostics segment dominated the market, with a share of around 56% in 2022. Clinical diagnostics is the approximated diagnosis of the underlying illnesses deduced through the patient's symptoms and medical history. Proteomics is essential in the vast spectrum of preclinical diagnostic tools for cancer disorders, early disease diagnosis, prognosis, and disease development monitoring. Applying proteomics to clinical samples like blood, urine, serum, and other biological fluids is known as clinical proteomics. Studying clinical proteomics is relevant and significant from a practical standpoint since protein is the basic, fundamental unit of cellular functions, features, and pathways.

Technology Segment Analysis

The technology segment is divided into microarray instruments, spectroscopy, protein fractionation systems, surface plasma resonance systems, X-ray crystallography, chromatography, and electrophoresis. The spectroscopy segment dominated the market, with a market share of around 35% in 2022. The structure of atoms and molecules of unknown chemicals can be studied using spectroscopy. Spectroscopy allows researchers to examine structures in great detail. Spectroscopy is used for Numerous diagnostic and therapeutic applications in biomedicine. For instance, photon time-of-flight spectroscopy may be useful in developing some treatment approaches. Additionally, spectroscopy offers a precise analytical technique. Proteomics using mass spectrometry is very repeatable.

  • September 2023 - The development of technology that makes protein sequencing simple has been the focus of a true race among scientists. Giovanni Maglia, a professor of chemical biology at the University of Groningen, has discovered the solution to the puzzle's final unsolved problem: moving a protein through a nanopore to be sequenced on a cheap, portable device. Sequencing proteins is the next great challenge after DNA sequencing, revolutionising our understanding of life. Maglia employed a solution of electrically charged particles (ions), which can be drawn through the nanopore with an electric field, to transport a protein through the structure. They move the protein along when this occurs. Maglia created a system without proteins that has the strongest flow imaginable.
Some of the Key Market Players:
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Illumina, Inc.
  • Merck KGaA.
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.

Report Description: 

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 25 Billion
Market size value in 2032 USD 101.13 Billion
CAGR (2023 to 2032) 15%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, the Middle East and Africa. Furthermore, the regions are further analyzed at the country level.
Segments Product Type, Application, and Technology

Frequesntly Asked Questions

As per The Brainy Insights, the size of the global proteomics market was valued at USD 25 billion in 2022 to USD 101.13 billion by 2032.

Global proteomics market is growing at a CAGR of 15% during the forecast period 2023-2032.

The market's growth will be influenced by the technological advancements.

The high costs of proteomics could hamper the market growth.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Product Type
          4.3.2. Market Attractiveness Analysis by Application
          4.3.3. Market Attractiveness Analysis by Technology
          4.3.4. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. The technological advancements
    5.3. Restraints
          5.3.1. The high cost of Proteomics
    5.4. Opportunities
          5.4.1. The increasing applications of proteomics
    5.5. Challenges
          5.5.1. Lack of data security regulation

6. Global Proteomics Market Analysis and Forecast, By Product Type
    6.1. Segment Overview
    6.2. Instruments
    6.3. Services
    6.4. Reagents and Consumables
    6.5. Others

7. Global Proteomics Market Analysis and Forecast, By Application
    7.1. Segment Overview
    7.2. Drug Discovery
    7.3. Clinical Diagnostics
    7.4. Others

8. Global Proteomics Market Analysis and Forecast, By Technology
    8.1. Segment Overview
    8.2. Microarray Instruments
    8.3. Spectroscopy
    8.4. Protein Fractionation Systems
    8.5. Surface Plasma Resonance Systems
    8.6. X-Ray Crystallography
    8.7. Chromatography
    8.8. Electrophoresis

9. Global Proteomics Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Proteomics Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in the Proteomics Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Agilent Technologies, Inc.
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Bio - Rad Laboratories, Inc.
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Bruker Corporation
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Danaher Corporation
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. F. Hoffmann-La Roche Ltd.
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. GE Healthcare
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Illumina, Inc.
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Merck KGaA.
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. PerkinElmer, Inc.
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Thermo Fisher Scientific Inc.
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis

List of Table

1. Global Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

2. Global Instruments Proteomics Market, By Region, 2019-2032 (USD Billion) 

3. Global Services Proteomics Market, By Region, 2019-2032 (USD Billion) 

4. Global Reagents and Consumables Proteomics Market, By Region, 2019-2032 (USD Billion) 

5. Global Others Proteomics Market, By Region, 2019-2032 (USD Billion) 

6. Global Proteomics Market, By Application, 2019-2032 (USD Billion) 

7. Global Drug Discovery Proteomics Market, By Region, 2019-2032 (USD Billion) 

8. Global Clinical Diagnostics Proteomics Market, By Region, 2019-2032 (USD Billion) 

9. Global Others Proteomics Market, By Region, 2019-2032 (USD Billion) 

10. Global Proteomics Market, By Technology, 2019-2032 (USD Billion) 

11. Global Microarray Instruments Proteomics Market, By Region, 2019-2032 (USD Billion) 

12. Global Spectroscopy Proteomics Market, By Region, 2019-2032 (USD Billion) 

13. Global Protein Fractionation Systems Proteomics Market, By Region, 2019-2032 (USD Billion) 

14. Global Surface Plasma Resonance Systems Proteomics Market, By Region, 2019-2032 (USD Billion) 

15. Global X-Ray Crystallography Proteomics Market, By Region, 2019-2032 (USD Billion) 

16. Global Chromatography Proteomics Market, By Region, 2019-2032 (USD Billion) 

17. Global Electrophoresis Proteomics Market, By Region, 2019-2032 (USD Billion) 

18. Global Proteomics Market, By Region, 2019-2032 (USD Billion) 

19. North America Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

20. North America Proteomics Market, By Application, 2019-2032 (USD Billion) 

21. North America Proteomics Market, By Technology, 2019-2032 (USD Billion) 

22. U.S. Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

23. U.S. Proteomics Market, By Application, 2019-2032 (USD Billion) 

24. U.S. Proteomics Market, By Technology, 2019-2032 (USD Billion) 

25. Canada Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

26. Canada Proteomics Market, By Application, 2019-2032 (USD Billion) 

27. Canada Proteomics Market, By Technology, 2019-2032 (USD Billion) 

28. Mexico Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

29. Mexico Proteomics Market, By Application, 2019-2032 (USD Billion) 

30. Mexico Proteomics Market, By Technology, 2019-2032 (USD Billion) 

31. Europe Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

32. Europe Proteomics Market, By Application, 2019-2032 (USD Billion) 

33. Europe Proteomics Market, By Technology, 2019-2032 (USD Billion) 

34. Germany Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

35. Germany Proteomics Market, By Application, 2019-2032 (USD Billion) 

36. Germany Proteomics Market, By Technology, 2019-2032 (USD Billion) 

37. France Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

38. France Proteomics Market, By Application, 2019-2032 (USD Billion) 

39. France Proteomics Market, By Technology, 2019-2032 (USD Billion) 

40. U.K. Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

41. U.K. Proteomics Market, By Application, 2019-2032 (USD Billion) 

42. U.K. Proteomics Market, By Technology, 2019-2032 (USD Billion) 

43. Italy Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

44. Italy Proteomics Market, By Application, 2019-2032 (USD Billion) 

45. Italy Proteomics Market, By Technology, 2019-2032 (USD Billion) 

46. Spain Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

47. Spain Proteomics Market, By Application, 2019-2032 (USD Billion) 

48. Spain Proteomics Market, By Technology, 2019-2032 (USD Billion) 

49. Asia Pacific Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

50. Asia Pacific Proteomics Market, By Application, 2019-2032 (USD Billion) 

51. Asia Pacific Proteomics Market, By Technology, 2019-2032 (USD Billion) 

52. Japan Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

53. Japan Proteomics Market, By Application, 2019-2032 (USD Billion) 

54. Japan Proteomics Market, By Technology, 2019-2032 (USD Billion) 

55. China Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

56. China Proteomics Market, By Application, 2019-2032 (USD Billion) 

57. China Proteomics Market, By Technology, 2019-2032 (USD Billion) 

58. India Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

59. India Proteomics Market, By Application, 2019-2032 (USD Billion) 

60. India Proteomics Market, By Technology, 2019-2032 (USD Billion) 

61. South America Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

62. South America Proteomics Market, By Application, 2019-2032 (USD Billion)

63. South America Proteomics Market, By Technology, 2019-2032 (USD Billion)

64. Brazil Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

65. Brazil Proteomics Market, By Application, 2019-2032 (USD Billion) 

66. Brazil Proteomics Market, By Technology, 2019-2032 (USD Billion)

67. Middle East and Africa Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

68. Middle East and Africa Proteomics Market, By Application, 2019-2032 (USD Billion) 

69. Middle East and Africa Proteomics Market, By Technology, 2019-2032 (USD Billion)

70. UAE Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

71. UAE Proteomics Market, By Application, 2019-2032 (USD Billion) 

72. UAE Proteomics Market, By Technology, 2019-2032 (USD Billion)

73. South Africa Proteomics Market, By Product Type, 2019-2032 (USD Billion) 

74. South Africa Proteomics Market, By Application, 2019-2032 (USD Billion) 

75. South Africa Proteomics Market, By Technology, 2019-2032 (USD Billion) 

List of Figures 

1. Global Proteomics Market Segmentation

2. Proteomics Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Proteomics Market Attractiveness Analysis by Product Type

9. Global Proteomics Market Attractiveness Analysis by Application

10. Global Proteomics Market Attractiveness Analysis by Technology

11. Global Proteomics Market Attractiveness Analysis by Region

12. Global Proteomics Market: Dynamics

13. Global Proteomics Market Share by Product Type (2022 & 2032)

14. Global Proteomics Market Share by Application (2022 & 2032)

15. Global Proteomics Market Share by Technology (2022 & 2032)

16. Global Proteomics Market Share by Regions (2022 & 2032)

17. Global Proteomics Market Share by Company (2022)

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global proteomics market based on below mentioned segments:

Global Proteomics Market by Product Type:

  • Instruments
  • Services
  • Reagents and Consumables
  • Others

Global Proteomics Market by Application:

  • Drug Discovery
  • Clinical Diagnostics
  • Others

Global Proteomics Market by Technology:

  • Microarray Instruments
  • Spectroscopy
  • Protein Fractionation Systems
  • Surface Plasma Resonance Systems
  • X-Ray Crystallography
  • Chromatography
  • Electrophoresis

Global Proteomics Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date